_LOMINA LOGO 2020-01.png

SUPERBio COVID-19 kit adopts fluorescence immunochromatography.

The test card contains

① colloidal gold- labeled antigen and quality control antibody complex;

② nitrocellulose membranes fixed with two test lines (M line and G line) and one quality control line (C line).

When an appropriate amount of sample is added to the sample well of the test card, the sample will move forward along the test card due to capillary action. If the sample contains IgM/IgG antibody of COVID-19, the antibody will bind to the colloidal gold-labeled COVID-19 antigen, and the  immune complex will be captured by the monoclonal IgM antibody or monoclonal IgG antibody immobilized on the nitrocellulose membrane, forming a purple red M line or G line, and showing that the sample is positive for IgM or IgG antibody.

IgM and IgG are the first antibodies appearing in the human immune system during infection Because of their high specicity,when detecting acute COVID-19 infection, IgM and IgG antibodies have the advantages of high sensitivity,early diagnosis, and the ability to judge whether a suspect is infected. 

IgM and IgG antibodies can only be produced after several days ofvrral infection and differ between individuals.

Positive result (+):

Indicating that there may be a recent infection. Combined with relevant clinical symptoms, further testing is recommended. 

Negative result(-):

Indicating that there is no infection, or in very early stage or recovery period. 

                                                                                                                                          See the manual for details!

 
 

Available COVID-19 IgM/IgG DETECTION KIT

8. minutes for a result

RAPID TESTER 10 pieces pack

 

RAPID TESTER 20 pieces pack

 

RAPID TESTER 1000 pieces +

 

RAPID TESTER 10.000 pieces +

Due to high demand we only supply 1000+

Call for price

​​LEGAL DISCLAIMER

The product is under certification according to REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL from 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU.  The certification is not completed yet!

Typically, approval procedure takes several months up to 1 year.

Until completion of the certification process, the product can not be distributed by any European company or by an individual. 

We can therefore only offer you direct sale from China where the testing was done and where it is practically used at WuHan hospitals.

Such a purchase can not be considered as placing on the market or as putting into service by Lomina AG group.

 

Open the packing box, take out-the inner package and let it equilibrate to room temperature. Please read the operation manual completely first, and use the kit immediately but no longer than within 1 hour after opening the aluminum protective cover.

 

DNA sequencing by methods

FORENSIC BIOLOGY EVIDENCE IDENTIFICATION

Fluorescent-labeled STR multiplex amplification kit, Capillary electrophoretic separation, Genotyping

FORENSIC CLINICAL AUTHENTICATION

+

FORENSIC PATHOLOGICAL ANALYSIS

+

FORENSIC TOXICOLOGICAL ANALYSIS

Relative standards of P.R.C. 

UV - visible spectrophotometry, Gas chromatography 

MEDICAL EXAMINATION

+

TRACE EVIDENCE IDENTIFICATION

Fluorescent Quantitation PCR ,

Sanger sequencing,

DNA Sequencer I,

DNA Sequencer II

 

CONTACT

kroutil (a) lomina.ch
brzobohaty (a) lomina.ch
kalivodova (a) lomina.ch
+420 722 633 203
zalesky (a) lomina.ch
pysik (a) lomina.ch
+420 722 633 203
zalesky (a) lomina.ch
+421  
+43 681 8460 7684
sommer (a) lomina.ch
+41 76 399 40 73
reist (a) lomina.ch
Osvaldo NETO
neto (a) lomina.ch
+258  853 00 00 30

EAST AFRICA

MALAWI 

MOZAMBIQUE

ZIMBABWE